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Abstract
Introduction: We report the case of a patient in whom simultaneous toric phakic intraocular lens removal and
phacoemulsification with toric intraocular lens implantation were beneficial for reducing pre-existing astigmatism
and acquiring good visual outcomes in eyes with implantable collamer lens-induced cataract and astigmatism.
Case presentation: A 53-year-old woman had undergone toric implantable collamer lens implantation three years
earlier. After informed consent was obtained, we performed simultaneous toric implantable collamer lens removal
and phacoemulsification with toric intraocular lens implantation. Preoperatively, the manifest refraction was 0, -0.5
× 15, with an uncorrected visual acuity of 0.7 and a best spectacle-corrected visual acuity of 0.8. Postoperatively,
the manifest refraction was improved to 0, -0.5 × 180, with an uncorrected visual acuity of 1.2 and a best
spectacle-corrected visual acuity of 1.5. No vision-threatening complications were observed.
Conclusion: Toric intraocular lens implantation may be a good surgical option for the correction of spherical and
cylindrical errors in eyes with implantable collamer lens-induced cataract and astigmatism.
Introduction
The Visian Implantable Collamer Lens (Visian ICL,
STAAR Surgical, Nidau, Switzerland), a posterior cham-
ber phakic intraocular lens (IOL), has been reported for
superiority not only in postoperative visual performance
compared to laser in situ keratomileusis but also for
safety and effectiveness in the correction of moderate to
high ametropia [1-3]. In addition, this surgical proce-
dure is largely reversible and the lens exchangeable with
another lens, unlike laser in situ keratomileusis, even
when unexpected refractive changes occur after surgery.
Recently, toric ICL implantation has also been demon-
strated to be an effective means for the correction of
high myopic astigmatism [3-6]. However, there are
ongoing concerns about the development of lens opacity
after both non-toric and toric ICL implantation, because
of the close proximity of the ICL to the crystalline lens,
and about endothelial cell loss after surgery. In light of
the prevalence of this surgical procedure, it is clinically
i m p o r t a n tt oa s s e s st h ep r o g n o s i so fp a t i e n t sw i t ha
developing cataract after ICL implantation.
Simultaneous ICL removal and phacoemulsification
with conventional IOL implantation has been reported
to be safe and effective with predictable refractive
results, and thus yield a high level of satisfaction for
these patients [7-9]. However, toric ICL removal and
non-toric IOL implantation may lead to an increase in
astigmatism in toric ICL-implanted eyes, because these
eyes have some corneal astigmatism, and this astigma-
tism remains after these combined procedures.
Reducing this pre-existing astigmatism and acquiring
good visual outcomes are essential to minimize spectacle
dependence and maximize subsequent patient satisfac-
tion, even for patients with ICL-induced cataracts.
Nevertheless, to the best of our knowledge, there have
been no previous case reports on the management of
ICL-induced cataracts and astigmatism by phacoemulsi-
fication with toric IOL implantation. We present here a
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removal and phacoemulsification with toric IOL implan-
tation was beneficial for acquiring a good visual out-
come in an eye with an ICL-induced cataract and
astigmatism.
Case presentation
A 53-year-old woman, who had undergone bilateral
toric ICL implantation for treatment of high myopic
astigmatism in both eyes three years earlier, visited our
hospital complaining of blurred vision in her left eye. In
that eye, the manifest refraction was 0, -0.5 × 15, with
an uncorrected visual acuity (UCVA) of 0.7 and a best
spectacle-corrected visual acuity (BSCVA) of 0.8. The
ICL vault (the distance between the posterior surface of
the ICL and the anterior surface of the crystalline lens)
was 0.16 mm; the keratometry, 42.8/45.2D × 95; the
endothelial cell density, 2924 cells/mm
2;a n dt h ec e n t r a l
corneal thickness, 529 μm (Table 1).
Slit-lamp examination showed a marked anterior sub-
capsular cataract reaching into the visual axis (Figure 1).
The remainder of the examination was unremarkable.
After informed consent was obtained, we performed
simultaneous toric ICL removal and phacoemulsification
with toric IOL implantation. IOL spherical power calcu-
lations were performed by the SRK-T formula using the
axial length measured by A-scan ultrasonography (US-
800, Nidek, Aichi, Japan), and keratometric readings
measured with an autorefractometer (RK-5, Canon,
Tokyo, Japan). IOL cylinder power and the alignment
axis were calculated using a Web-based toric IOL calcu-
lator program [10], along with the default surgically
induced astigmatism, which the software considered as
0.5D. To control for potential cyclotorsion, the horizon-
tal axis was marked preoperatively using a slit-lamp in a
supine position. For ICL removal and phacoemulsifica-
tion with toric IOL implantation, a 3.0 mm temporal
clear corneal incision at a site identical to the original
incision was created after topical anesthesia. After the
introduction of viscoelastic material (Opegan; Santen,
Osaka, Japan) into the anterior chamber, the proximal
haptics of the ICL were dislocated, grasped with forceps,
and extracted from the anterior chamber through the
incision. Then, standard phacoemulsification was per-
formed by capsulorrhexis, nuclear and cortex extraction,
and toric IOL (SA60AT5, power +9.5D; Alcon Labora-
tories Inc., Fort Worth, Texas, USA) implantation using
the same 3.0 mm incision. After surgery, our patient
received steroidal (0.1% betamethasone; Rinderon, Shio-
nogi, Tokyo, Japan), antibiotic (0.5% levofloxacin; Cravit,
Santen) and non-steroidal diclofenac sodium 0.1%
(Diclod, Wakamoto, Tokyo, Japan) medications, which
were topically administered four times daily for one
month and then the dose steadily reduced.
On day 1, our patient’sU C V Aw a s1 . 2 .O n em o n t h
after surgery, the mean refraction was 0, -0.5 × 180, and
s h eh a daU C V Ao f1 . 2a n daB S C V Ao f1 . 5 ,a n dt h e
keratometry was 42.8/45.5D × 100. The surgically
induced corneal astigmatism was 0.54D × 126. Her
endothelial cell density was 2801 cells/mm
2 (Table 1),
and our patient was very satisfied with the postoperative
visual outcomes. No vision-threatening complications
occurred, including rotation of the IOL, and the mani-
fest refraction and her visual acuity remained stable
throughout the six-month follow-up period.
Discussion
As far as we can ascertain, this is the first case report
on the management of ICL-induced cataract and astig-
matism by phacoemulsification with toric IOL implan-
tation. Recently, toric ICL implantation has also been
demonstrated to be effective for the correction of high
myopic astigmatism [3-6]. However, the possible risk
of cataract formation was not negligible, especially in
Table 1 Preoperative and postoperative data
Preoperative Postoperative (one
month)
Mean refraction 0, -0.5 × 15 0, -0.5 × 180
Uncorrected visual acuity 0.7 1.2
Best spectacle corrected visual
acuity
0.8 1.5
Keratometry (D) 42.8/45.2 ×
95
42.8/45.5 × 100
Corneal astigmatism (D) 2.4 2.7
Endothelial cell density (cells/
mm
2)
2,924 2,801
Central corneal thickness (μm) 529 530
Intraocular pressure (mmHg) 12 10
Figure 1 Preoperative slit-lamp examination disclosed a
marked anterior subcapsular cataract reaching as far as the
axial area.
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underwent not only non-toric but also toric ICL
implantation. It is of clinical importance to reduce
pre-existing astigmatism and to acquire good visual
outcomes, particularly in toric ICL-implanted eyes,
because toric ICL-implanted eyes have a certain
amount of astigmatic error and deteriorated quality of
vision, and because patients who have undergone
refractive surgery typically desire the best uncorrected
visual outcomes.
In recent years, toric IOL implantation has been
reported to be effective for the correction of spherical
and cylindrical errors in cataractous eyes having some
corneal astigmatism. The Acrysof toric IOL has pro-
vided excellent rotational stability in comparison with
other toric IOLs, and so we selected this IOL for our
patient to acquire good UCVA. Although toric multifo-
cal IOL implantation is not available in Japan, it may
a l s ob eav i a b l es u r g i c a lo p t i on for patients with catar-
acts and astigmatism who demand good visual acuity
without glasses for both far and near.
With regard to the predictability of these surgical
procedures, Bleckmann and Keuch stated that refrac-
tive error in the eyes has never exceeded the value of
1D, independent of the initial refraction or degree of
hyperopia or myopia [7]. Morales et al. reported that
the percentage of eyes within ± 1.0D of the targeted
correction was 71.4% [8]. We have also previously
demonstrated that, three months after surgery, the per-
centage of eyes within ± 0.5D of the targeted correc-
tion was 80%, and within ± 1.0D of the targeted
correction was 90% [9]. In this study, we measured the
axial length by A-scan ultrasonography without any
correction, and used the SRK-T formula to calculate
spherical IOL power for this patient after toric ICL
implantation. Hoffer et al. reported that the greatest
difference in A-scan axial length measurements occurs
with a silicone IOL in an eye with very high hyperopia,
and that the least difference will occur with a collamer
lens (ICL) in an eye with very high myopia [13]. Mor-
ales et al. also stated that the difference between the
axial length measurements before and after ICL
implantation was small [8]. These findings may partly
account for the higher predictability of these combined
procedures.
Conclusion
The findings of our case report suggest that the use of a
toric IOL may be an alternative for the treatment of
spherical and cylindrical errors in eyes with an ICL-
induced cataract and astigmatism. We also suggest that
standard biometric measurements can be obtained and
used in effective IOL power calculations in the event of
a cataract after ICL surgery, regardless of whether or
not the ICL was spherical or toric. Considering that
toric ICL-implanted eyes have a certain amount of cor-
neal astigmatism, which can decrease uncorrected acuity
and deteriorate quality of vision, the preliminarily results
are encouraging. A further study in a large series of
patients should be conducted to confirm these prelimin-
ary findings.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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